Intestinal transplantation at the University of Pittsburgh. 1994

S Todo, and A Tzakis, and J Reyes, and K Abu-Elmagd, and H Furukawa, and B Nour, and Z Kadry, and J Fung, and T E Starzl
Pittsburgh Transplantation Institute, University of Pittsburgh Medical Center, Pennsylvania.

Our experience with clinical intestinal transplantation under FK 506 immunosuppression showed that 50% of the recipients were able to be independent from TPN after transplantation, but 10% require partial TPN with functioning grafts, 10% needed total TPN after graft removal, and 30% of the recipients died postoperatively, mostly from sepsis due to severe graft rejection. For further improvement in patient survival and in the quality of life for patients after intestinal transplantation, it is mandatory to establish a new strategy for treatment and prevention of graft rejection and systemic infection.

UI MeSH Term Description Entries
D007422 Intestines The section of the alimentary canal from the STOMACH to the ANAL CANAL. It includes the LARGE INTESTINE and SMALL INTESTINE. Intestine
D010289 Parenteral Nutrition, Total The delivery of nutrients for assimilation and utilization by a patient whose sole source of nutrients is via solutions administered intravenously, subcutaneously, or by some other non-alimentary route. The basic components of TPN solutions are protein hydrolysates or free amino acid mixtures, monosaccharides, and electrolytes. Components are selected for their ability to reverse catabolism, promote anabolism, and build structural proteins. Hyperalimentation, Parenteral,Intravenous Hyperalimentation,Nutrition, Total Parenteral,Parenteral Hyperalimentation,Total Parenteral Nutrition,Hyperalimentation, Intravenous
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006084 Graft Rejection An immune response with both cellular and humoral components, directed against an allogeneic transplant, whose tissue antigens are not compatible with those of the recipient. Transplant Rejection,Rejection, Transplant,Transplantation Rejection,Graft Rejections,Rejection, Graft,Rejection, Transplantation,Rejections, Graft,Rejections, Transplant,Rejections, Transplantation,Transplant Rejections,Transplantation Rejections
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

S Todo, and A Tzakis, and J Reyes, and K Abu-Elmagd, and H Furukawa, and B Nour, and Z Kadry, and J Fung, and T E Starzl
January 1998, Clinical transplants,
S Todo, and A Tzakis, and J Reyes, and K Abu-Elmagd, and H Furukawa, and B Nour, and Z Kadry, and J Fung, and T E Starzl
November 1996, Nihon Geka Gakkai zasshi,
S Todo, and A Tzakis, and J Reyes, and K Abu-Elmagd, and H Furukawa, and B Nour, and Z Kadry, and J Fung, and T E Starzl
January 1997, Transplantation proceedings,
S Todo, and A Tzakis, and J Reyes, and K Abu-Elmagd, and H Furukawa, and B Nour, and Z Kadry, and J Fung, and T E Starzl
August 2002, Transplantation proceedings,
S Todo, and A Tzakis, and J Reyes, and K Abu-Elmagd, and H Furukawa, and B Nour, and Z Kadry, and J Fung, and T E Starzl
January 2011, Clinical transplants,
S Todo, and A Tzakis, and J Reyes, and K Abu-Elmagd, and H Furukawa, and B Nour, and Z Kadry, and J Fung, and T E Starzl
January 2011, Clinical transplants,
S Todo, and A Tzakis, and J Reyes, and K Abu-Elmagd, and H Furukawa, and B Nour, and Z Kadry, and J Fung, and T E Starzl
January 1992, Clinical transplants,
S Todo, and A Tzakis, and J Reyes, and K Abu-Elmagd, and H Furukawa, and B Nour, and Z Kadry, and J Fung, and T E Starzl
January 2004, Clinical transplants,
S Todo, and A Tzakis, and J Reyes, and K Abu-Elmagd, and H Furukawa, and B Nour, and Z Kadry, and J Fung, and T E Starzl
February 1994, Transplantation proceedings,
S Todo, and A Tzakis, and J Reyes, and K Abu-Elmagd, and H Furukawa, and B Nour, and Z Kadry, and J Fung, and T E Starzl
January 1994, Clinical transplants,
Copied contents to your clipboard!